Xcout Intel
Biorce
Biorce is a biotechnology research company headquartered in Barcelona, Spain, with a team of around 180 employees. The company develops artificial intelligence platforms and operating systems designed to automate and streamline clinical trials with built-in review processes and human oversight.
Subscribe to see Biorce’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biorce at a glance
Biorce is a biotech company headquartered in Spain. It has raised at least $56.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $52.5M in February 2026. Xcout tracks 2 named people at Biorce, including Pedro Coelho (CEO).
Biorce leadership
- Pedro CoelhoCEO
- Pedro CoelhoFounder
Biorce funding rounds
At least $56.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $52.5M | 7 named | |
| Series A | $3.8M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Biorce competitors
A few of Biorce's closest competitors — see the full list of competitors and alternatives →
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
ArcaScience is a pharmaceutical artificial intelligence company headquartered in Paris, France, that develops an advanced benefit-risk decision engine and drug safety platforms.
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Ryght AI is an artificial intelligence company headquartered in Southern California that provides an AI-powered platform to rapidly analyze clinical trial protocols and connect researchers with sites worldwide.
Get Biorce's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Biorce in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access